Two Sigma Advisers’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
KGAMU
6CM
WPM
QOP
RC
Two Sigma Advisers's CDLX Position: Q3 2025 in Review
Two Sigma Advisers sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 4,275 shares — an estimated $70.3K sold.
Two Sigma Advisers first reported a position in CDLX in Q4 2019 and held it in 17 quarters. The position peaked at $4.32M in Q3 2022. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.
- Two Sigma Advisers reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
- Two Sigma Advisers sold 4,275 Cardlytics shares in Q3 2025, an estimated $70.3K.
- Two Sigma Advisers first reported a position in Cardlytics in Q4 2019 and held it in 17 quarters.
- Two Sigma Advisers's Cardlytics position peaked at $4.32M in Q3 2022.
- 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.
Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.